Baird Financial Group
ALDR

Baird Financial Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Baird Financial Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-54,615
Closed -$560K – 1349
2018
Q4 		$560K Buy
54,615
+3,840
+8% +$49.2K ﹤0.01% 953
2018
Q3 		$755K Buy
50,775
+1,021
+2% +$18.5K ﹤0.01% 925
2018
Q2 		$786K Buy
49,754
+403
+0.8% +$6.12K 0.01% 885
2018
Q1 		$627K Sell
49,351
-9,989
-17% -$144K ﹤0.01% 950
2017
Q4 		$679K Sell
59,340
-12,592
-18% -$141K ﹤0.01% 925
2017
Q3 		$881K Buy
71,932
+43,996
+157% +$459K 0.01% 834
2017
Q2 		$320K Buy
27,936
+9,495
+51% +$176K ﹤0.01% 1070
2017
Q1 		$384K Buy
18,441
+1,349
+8% +$29.9K ﹤0.01% 1016
2016
Q4 		$356K Buy
17,092
+1,841
+12% +$47.9K ﹤0.01% 1013
2016
Q3 		$500K Sell
15,251
-479
-3% -$14.6K ﹤0.01% 937
2016
Q2 		$402K Buy
+15,730
New +$426K ﹤0.01% 969

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Baird Financial Group's ALDR Position: Q1 2019 in Review

Baird Financial Group sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 54,615 shares — an estimated $560K sold.

Baird Financial Group first reported a position in ALDR in Q2 2016 and held it in 11 quarters. The position peaked at $881K in Q3 2017. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Baird Financial Group reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Baird Financial Group sold 54,615 Alder Biopharmaceuticals shares in Q1 2019, an estimated $560K.
  • Baird Financial Group first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 11 quarters.
  • Baird Financial Group's Alder Biopharmaceuticals position peaked at $881K in Q3 2017.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Baird Financial Group's 13F filing for Q1 2019, filed 14 May 2019.